PIM
BOLD

Partner Investment Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

Partner Investment Management’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1.06M Sell
17,795
-7,575
-30% -$284K 7.65% 1
2019
Q3 		$713K Sell
25,370
-693
-3% -$23.7K 1.22% 33
2019
Q2 		$987K Buy
26,063
+9,240
+55% +$355K 1.05% 37
2019
Q1 		$656K Sell
16,823
-6,403
-28% -$184K 0.76% 50
2018
Q4 		$495K Buy
23,226
+9,374
+68% +$242K 0.62% 50
2018
Q3 		$548K Buy
13,852
+9,619
+227% +$359K 0.42% 75
2018
Q2 		$162K Buy
+4,233
New +$157K 0.13% 99

Other funds holding BOLD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Partner Investment Management's BOLD Position: Q4 2019 in Review

Partner Investment Management reduced its Audentes Therapeutics, Inc (BOLD) stake by 30% in Q4 2019, selling an estimated $284K and leaving 17,795 shares worth $1.06M. The position accounts for 7.65% of the portfolio, ranked #1.

Partner Investment Management first reported a position in BOLD in Q2 2018 and has held it in 7 quarters since. 188 funds tracked by Wall St. Rank hold BOLD as of Q4 2019.

  • Partner Investment Management held 17,795 shares of Audentes Therapeutics, Inc worth $1.06M as of Q4 2019.
  • Partner Investment Management sold 7,575 Audentes Therapeutics, Inc shares in Q4 2019, an estimated $284K.
  • Audentes Therapeutics, Inc made up 7.65% of Partner Investment Management's portfolio in Q4 2019, its #1 holding.
  • Partner Investment Management first reported a position in Audentes Therapeutics, Inc in Q2 2018 and has held it in 7 quarters since.
  • 188 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q4 2019.

Based on Partner Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.